Fosamprenavir | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Fosamprenavir
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Fosamprenavir

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

7 API Suppliers, 4 USDMF, 1 EU WC, 3 NDC API, 4 Listed Suppliers

7 API Suppliers
4 USDMF
1 EU WC
3 NDC API
4 Listed Suppliers

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

14 FDF Dossiers, 5 FDA Orange Book, 5 Europe, 2 Canada, 2 South Africa

14 FDF Dossiers
5 FDA Orange Book
5 Europe
2 Canada
2 South Africa

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 3 DKSH, 1 Pharm-RX Chemical, 4 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 3 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 12 BASF, 1 Bioplus Life Sciences, 10 Corel Pharma Chem, 3 DFE Pharma, 2 Finar, 10 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 15 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Nanjing Bold Chemical, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 10 Roquette, 12 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 9 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Coating Systems & Additives, 32 Fillers, Diluents & Binders, 22 Controlled & Modified Release, 20 Solubilizers, 15 Thickeners and Stabilizers, 15 Disintegrants & Superdisintegrants, 14 Granulation, 14 Direct Compression, 13 Film Formers & Plasticizers, 11 Lubricants & Glidants, 10 Parenteral, 8 Emulsifying Agents, 8 Co-Processed Excipients, 6 API Stability Enhancers, 6 Taste Masking, 6 Topical, 5 Empty Capsules, 4 Coloring Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules, 3 Chewable & Orodispersible Aids, 2 Surfactant & Foaming Agents

44 Coating Systems & Additives
32 Fillers, Diluents & Binders
22 Controlled & Modified Release
20 Solubilizers
15 Thickeners and Stabilizers
15 Disintegrants & Superdisintegrants
14 Granulation
14 Direct Compression
13 Film Formers & Plasticizers
11 Lubricants & Glidants
10 Parenteral
8 Emulsifying Agents
8 Co-Processed Excipients
6 API Stability Enhancers
6 Taste Masking
6 Topical
5 Empty Capsules
4 Coloring Agents
4 Rheology Modifiers
4 Vegetarian Capsules
3 Chewable & Orodispersible Aids
2 Surfactant & Foaming Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow

1 DATA COMPILATION #PharmaFlow

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 4 Finished Drug Prices, 3 Annual Reports

2 US Medicaid Prescriptions
4 Finished Drug Prices
3 Annual Reports

MARKET PLACE

2 APIs, 1 FDF Dossiers

2 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

6 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 6GlaxoSmithKline Inc.

filter Patent Reset all filters

6 All

01 22224738

02 22231700

03 22337857

filter Product Reset all filters

6 All

01 6Fosamprenavir Calcium

filter Dosage Reset all filters

6 All

01 3Oral Suspension

02 3Tablet

filter Exp Date Reset all filters

6 All

01 22016-06-28

02 22018-03-10

03 22019-07-15

Product Main Page

01

GlaxoSmithKline Inc.

Fosamprenavir

BioAsia

Not Confirmed

GlaxoSmithKline Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-06-28

Date Granted : 2002-08-27

Fosamprenavir

Brand Name : TELZIR

Patent Number : 2224738

Filing Date : 1996-06-28

Strength per Unit : 50 mg / ml

Dosage Form : Oral Suspension

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-06-28

Date Granted : 2002-08-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

GlaxoSmithKline Inc.

Fosamprenavir

BioAsia

Not Confirmed

GlaxoSmithKline Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-06-28

Date Granted : 2002-08-27

Fosamprenavir

Brand Name : TELZIR

Patent Number : 2224738

Filing Date : 1996-06-28

Strength per Unit : 700 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-06-28

Date Granted : 2002-08-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

GlaxoSmithKline Inc.

Fosamprenavir

BioAsia

Not Confirmed

GlaxoSmithKline Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-03-10

Date Granted : 2005-08-09

Fosamprenavir

Brand Name : TELZIR

Patent Number : 2231700

Filing Date : 1998-03-10

Strength per Unit : 50 mg / ml

Dosage Form : Oral Suspension

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-03-10

Date Granted : 2005-08-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

GlaxoSmithKline Inc.

Fosamprenavir

BioAsia

Not Confirmed

GlaxoSmithKline Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-07-15

Date Granted : 2011-01-25

Fosamprenavir

Brand Name : TELZIR

Patent Number : 2337857

Filing Date : 1999-07-15

Strength per Unit : 50 mg / ml

Dosage Form : Oral Suspension

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-07-15

Date Granted : 2011-01-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

GlaxoSmithKline Inc.

Fosamprenavir

BioAsia

Not Confirmed

GlaxoSmithKline Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-03-10

Date Granted : 2005-08-09

Fosamprenavir

Brand Name : TELZIR

Patent Number : 2231700

Filing Date : 1998-03-10

Strength per Unit : 700 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-03-10

Date Granted : 2005-08-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

GlaxoSmithKline Inc.

Fosamprenavir

BioAsia

Not Confirmed

GlaxoSmithKline Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-07-15

Date Granted : 2011-01-25

Fosamprenavir

Brand Name : TELZIR

Patent Number : 2337857

Filing Date : 1999-07-15

Strength per Unit : 700 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-07-15

Date Granted : 2011-01-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!